Table 2 Comorbidities and lung function parameters prior to surgery in patients with clinical stage III/N2 NSCLC
All patients (n = 84) | |
|---|---|
Comorbidities (Yes, n, %) | 59 (%) |
COPD a (n, %) | 34 (38.2%) |
Diabetes mellitus (n, %) | 12 (11.7%) |
Arterial hypertension (n, %) | 35 (26.5%) |
Cardiovascular disease (n, %) | 17 (14.7%) |
Previous Malignancies (n, %) | 13 (8.8%) |
FEV1%a (Mean ± SD) | 79.6% ± 20.8 |
FVC% a (Mean ± SD) | 86.3% ± 15.7 |
pO2 a (mmHg, Mean ± SD) | 72.3 ± 16.4 |
pCO2 a (mmHg, Mean ± SD) | 40.4 ± 12.0 |